ID   INP4A_HUMAN             Reviewed;         977 AA.
AC   Q96PE3; O15326; Q13187; Q53TD8; Q8TC02;
DT   30-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   15-MAR-2017, entry version 110.
DE   RecName: Full=Type I inositol 3,4-bisphosphate 4-phosphatase;
DE            EC=3.1.3.66;
DE   AltName: Full=Inositol polyphosphate 4-phosphatase type I;
GN   Name=INPP4A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=7608176; DOI=10.1074/jbc.270.27.16128;
RA   Norris F.A., Auethavekiat V., Majerus P.W.;
RT   "The isolation and characterization of cDNA encoding human and rat
RT   brain inositol polyphosphate 4-phosphatase.";
RL   J. Biol. Chem. 270:16128-16133(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RC   TISSUE=Brain;
RX   PubMed=9295334; DOI=10.1074/jbc.272.38.23859;
RA   Norris F.A., Atkins R.C., Majerus P.W.;
RT   "The cDNA cloning and characterization of inositol polyphosphate 4-
RT   phosphatase type II. Evidence for conserved alternative splicing in
RT   the 4-phosphatase family.";
RL   J. Biol. Chem. 272:23859-23864(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=11485317; DOI=10.1006/bbrc.2001.5331;
RA   Shearn C.T., Walker J., Norris F.A.;
RT   "Identification of a novel spliceoform of inositol polyphosphate 4-
RT   phosphatase type Ialpha expressed in human platelets: structure of
RT   human inositol polyphosphate 4-phosphatase type I gene.";
RL   Biochem. Biophys. Res. Commun. 286:119-125(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-355, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-487, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-487, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   INTERACTION WITH INPP5F.
RX   PubMed=25869668; DOI=10.1083/jcb.201409064;
RA   Nakatsu F., Messa M., Nandez R., Czapla H., Zou Y., Strittmatter S.M.,
RA   De Camilli P.;
RT   "Sac2/INPP5F is an inositol 4-phosphatase that functions in the
RT   endocytic pathway.";
RL   J. Cell Biol. 209:85-95(2015).
CC   -!- FUNCTION: Catalyzes the hydrolysis of the 4-position phosphate of
CC       phosphatidylinositol 3,4-bisphosphate, inositol 1,3,4-
CC       trisphosphate and inositol 3,4-bisphosphate.
CC   -!- CATALYTIC ACTIVITY: 1-phosphatidyl-myo-inositol 3,4-bisphosphate +
CC       H(2)O = 1-phosphatidyl-1D-myo-inositol 3-phosphate + phosphate.
CC   -!- PATHWAY: Signal transduction; phosphatidylinositol signaling
CC       pathway.
CC   -!- SUBUNIT: Interacts with INPP5F. {ECO:0000269|PubMed:25869668}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=Alpha-3;
CC         IsoId=Q96PE3-1; Sequence=Displayed;
CC       Name=2; Synonyms=Alpha-1;
CC         IsoId=Q96PE3-2; Sequence=VSP_015241;
CC       Name=3;
CC         IsoId=Q96PE3-3; Sequence=VSP_015240;
CC       Name=4; Synonyms=Beta;
CC         IsoId=Q96PE3-4; Sequence=VSP_015241, VSP_015242;
CC         Note=Inactive.;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is expressed in the platelets, MEG-
CC       01 megakaryocytes and Jurkat T-cells. Isoform 2 is expressed in
CC       the brain. {ECO:0000269|PubMed:11485317}.
CC   -!- SIMILARITY: Belongs to the inositol 3,4-bisphosphate 4-phosphatase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U26398; AAB01068.1; -; mRNA.
DR   EMBL; U96919; AAB72150.1; -; mRNA.
DR   EMBL; AF368319; AAK58870.1; -; mRNA.
DR   EMBL; AC010134; AAX93230.1; -; Genomic_DNA.
DR   EMBL; BC028361; AAH28361.1; -; mRNA.
DR   CCDS; CCDS46369.1; -. [Q96PE3-1]
DR   CCDS; CCDS46370.1; -. [Q96PE3-2]
DR   CCDS; CCDS46371.1; -. [Q96PE3-3]
DR   CCDS; CCDS46372.1; -. [Q96PE3-4]
DR   PIR; B57487; B57487.
DR   RefSeq; NP_001127696.1; NM_001134224.1. [Q96PE3-1]
DR   RefSeq; NP_001127697.1; NM_001134225.1. [Q96PE3-3]
DR   RefSeq; NP_001557.1; NM_001566.2. [Q96PE3-4]
DR   RefSeq; NP_004018.1; NM_004027.2. [Q96PE3-2]
DR   RefSeq; XP_016859487.1; XM_017003998.1. [Q96PE3-2]
DR   UniGene; Hs.469386; -.
DR   ProteinModelPortal; Q96PE3; -.
DR   SMR; Q96PE3; -.
DR   BioGrid; 109843; 6.
DR   IntAct; Q96PE3; 1.
DR   MINT; MINT-1188108; -.
DR   STRING; 9606.ENSP00000074304; -.
DR   SwissLipids; SLP:000000900; -.
DR   DEPOD; Q96PE3; -.
DR   iPTMnet; Q96PE3; -.
DR   PhosphoSitePlus; Q96PE3; -.
DR   BioMuta; INPP4A; -.
DR   DMDM; 73920059; -.
DR   EPD; Q96PE3; -.
DR   MaxQB; Q96PE3; -.
DR   PaxDb; Q96PE3; -.
DR   PeptideAtlas; Q96PE3; -.
DR   PRIDE; Q96PE3; -.
DR   DNASU; 3631; -.
DR   Ensembl; ENST00000074304; ENSP00000074304; ENSG00000040933. [Q96PE3-1]
DR   Ensembl; ENST00000409016; ENSP00000386704; ENSG00000040933. [Q96PE3-2]
DR   Ensembl; ENST00000409540; ENSP00000387294; ENSG00000040933. [Q96PE3-4]
DR   Ensembl; ENST00000409851; ENSP00000386777; ENSG00000040933. [Q96PE3-3]
DR   Ensembl; ENST00000523221; ENSP00000427722; ENSG00000040933. [Q96PE3-1]
DR   GeneID; 3631; -.
DR   KEGG; hsa:3631; -.
DR   UCSC; uc002syx.4; human. [Q96PE3-1]
DR   CTD; 3631; -.
DR   DisGeNET; 3631; -.
DR   GeneCards; INPP4A; -.
DR   HGNC; HGNC:6074; INPP4A.
DR   HPA; HPA001628; -.
DR   MIM; 600916; gene.
DR   neXtProt; NX_Q96PE3; -.
DR   OpenTargets; ENSG00000040933; -.
DR   PharmGKB; PA29882; -.
DR   eggNOG; KOG4428; Eukaryota.
DR   eggNOG; ENOG410YV83; LUCA.
DR   GeneTree; ENSGT00390000002033; -.
DR   HOGENOM; HOG000113075; -.
DR   HOVERGEN; HBG081796; -.
DR   InParanoid; Q96PE3; -.
DR   KO; K01109; -.
DR   OMA; TTHCSPP; -.
DR   OrthoDB; EOG091G02IJ; -.
DR   PhylomeDB; Q96PE3; -.
DR   TreeFam; TF325637; -.
DR   BioCyc; MetaCyc:HS00551-MONOMER; -.
DR   BRENDA; 3.1.3.66; 2681.
DR   Reactome; R-HSA-1660499; Synthesis of PIPs at the plasma membrane.
DR   Reactome; R-HSA-1660516; Synthesis of PIPs at the early endosome membrane.
DR   Reactome; R-HSA-1855183; Synthesis of IP2, IP, and Ins in the cytosol.
DR   UniPathway; UPA00944; -.
DR   ChiTaRS; INPP4A; human.
DR   GeneWiki; INPP4A; -.
DR   GenomeRNAi; 3631; -.
DR   PRO; PR:Q96PE3; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000040933; -.
DR   CleanEx; HS_INPP4A; -.
DR   ExpressionAtlas; Q96PE3; baseline and differential.
DR   Genevisible; Q96PE3; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0017161; F:inositol-1,3,4-trisphosphate 4-phosphatase activity; TAS:Reactome.
DR   GO; GO:0052828; F:inositol-3,4-bisphosphate 4-phosphatase activity; TAS:Reactome.
DR   GO; GO:0016316; F:phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity; IBA:GO_Central.
DR   GO; GO:0034597; F:phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome.
DR   GO; GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   Gene3D; 2.60.40.150; -; 1.
DR   InterPro; IPR000008; C2_dom.
DR   SUPFAM; SSF49562; SSF49562; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Hydrolase; Phosphoprotein;
KW   Polymorphism; Reference proteome.
FT   CHAIN         1    977       Type I inositol 3,4-bisphosphate 4-
FT                                phosphatase.
FT                                /FTId=PRO_0000190232.
FT   DOMAIN       31    137       C2.
FT   MOD_RES     355    355       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:15592455}.
FT   MOD_RES     487    487       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     389    393       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_015240.
FT   VAR_SEQ     574    613       GNPDSHAYWIRPEDPFCDVPSSPCPSTMPSTACHPHLTTH
FT                                -> D (in isoform 2 and isoform 4).
FT                                {ECO:0000303|PubMed:7608176,
FT                                ECO:0000303|PubMed:9295334}.
FT                                /FTId=VSP_015241.
FT   VAR_SEQ     935    977       EGCRRENTMKNVGSRKYAFNSLQLKAFPKHYRPPEGTYGKV
FT                                ET -> IGTREVVTQKNLSGLVPIRDLRLDPSLLCSIPLLA
FT                                LSPNLLIVWLFLSIAYLVTKLRCK (in isoform 4).
FT                                {ECO:0000303|PubMed:9295334}.
FT                                /FTId=VSP_015242.
FT   VARIANT     604    604       T -> A (in dbSNP:rs2278206).
FT                                /FTId=VAR_059359.
FT   CONFLICT    767    767       G -> E (in Ref. 5; AAH28361).
FT                                {ECO:0000305}.
SQ   SEQUENCE   977 AA;  109956 MW;  14087B24256B2D05 CRC64;
     MTAREHSPRH GARARAMQRA STIDVAADML GLSLAGNIQD PDEPILEFSL ACSELHTPSL
     DRKPNSFVAV SVTTPPQAFW TKHAQTEIIE GTNNPIFLSS IAFFQDSLIN QMTQVKLSVY
     DVKDRSQGTM YLLGSGTFIV KDLLQDRHHR LHLTLRSAES DRVGNITVIG WQMEEKSDQR
     PPVTRSVDTV NGRMVLPVDE SLTEALGIRS KYASLRKDTL LKSVFGGAIC RMYRFPTTDG
     NHLRILEQMA ESVLSLHVPR QFVKLLLEED AARVCELEEL GELSPCWESL RRQIVTQYQT
     IILTYQENLT DLHQYRGPSF KASSLKADKK LEFVPTNLHI QRMRVQDDGG SDQNYDIVTI
     GAPAAHCQGF KSGGLRKKLH KFEETKKHFE ECCTSSGCQS IIYIPQDVVR AKEIIAQINT
     LKTQVSYYAE RLSRAAKDRS ATGLERTLAI LADKTRQLVT VCDCKLLANS IHGLNAARPD
     YIASKASPTS TEEEQVMLRN DQDTLMARWT GRNSRSSLQV DWHEEEWEKV WLNVDKSLEC
     IIQRVDKLLQ KERLHGEGCE DVFPCAGSCT SKKGNPDSHA YWIRPEDPFC DVPSSPCPST
     MPSTACHPHL TTHCSPPPEE SSPGEWSEAL YPLLTTLTDC VAMMSDKAKK AMVFLLMQDS
     APTIATYLSL QYRRDVVFCQ TLTALICGFI IKLRNCLHDD GFLRQLYTIG LLAQFESLLS
     TYGEELAMLE DMSLGIMDLR NVTFKVTQAT SSASADMLPV ITGNRDGFNV RVPLPGPLFD
     ALPREIQSGM LLRVQPVLFN VGINEQQTLA ERFGDTSLQE VINVESLVRL NSYFEQFKEV
     LPEDCLPRSR SQTCLPELLR FLGQNVHARK NKNVDILWQA AEICRRLNGV RFTSCKSAKD
     RTAMSVTLEQ CLILQHEHGM APQVFTQALE CMRSEGCRRE NTMKNVGSRK YAFNSLQLKA
     FPKHYRPPEG TYGKVET
//
